Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-26

Clinical Trial Update: A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of a carcinoembryonic antigen (CEA)-targeted CAR-T therapy in patients with CEA-positive advanced solid tumors, including non-small cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEA-targeted CAR-T therapy (CAR-T cell therapy targeting carcinoembryonic antigen (CEA))

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: NSCLC (Advanced Non-small Cell Lung Cancer), Breast Cancer | Phase 1 | Status: RECRUITING